LIVN · LivaNova PLC
United States · RS rating 66 · As of 2026-10-14
| Price | 76.08 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 66 / 40 / 38 / 88 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 38 / 62 / 27 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +14.3% |
| Sales growth Q/Q | +0.9% |
| Distance from 52-week high | +10.8% |
| Market cap (USD) | $3.6B |